Using antipsychotics to prevent or treat delirium in postoperative hospitalized adults presents no clear benefits (but also no clear harms), according to a comparative effectiveness study. Across the studies analyzed, a small group found that compared with a placebo, second-generation antipsychotics (SGA) may slightly decrease the incidence of delirium.

The researchers concluded that although there was no clear evidence of harm, the slight benefit of SGAs on preventing postoperative delirium was offset by the cardiac side effects of first- and second-generation antipsychotics. They noted that the postoperative delirium studies were small, and that studies with larger groups might . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

The News

Daily coverage of the developments shaping health and human services. From policy shifts to program innovations, reports on trends-shaping mental health, addiction treatment, child and family services, autism and I/DD, disability support and long-term care, social services, corrections, juvenile justice, chronic disease management, health care systems, and more-helping leaders make timely, informed decisions.

Filter Options

  • By Market
  • By Topic
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters